Trial Profile
Safety and efficacy of ziv Aflibercept compounding in refractory diabetic macular oedema
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Diabetic macular oedema
- Focus Adverse reactions
- Acronyms zADMO
- 05 Jul 2016 New trial record